Veterinary Medicines

Twinox 400 mg/100 mg chewable tablets for dogs

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
Twinox 400 mg/100 mg chewable tablets for dogs
Twinox 400 mg/100 mg chewable tablets for dogs
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    459.22
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    119.13
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one sideand PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 300 tablets.
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one sideand PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 60 tablets.
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one sideand PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 12 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10774/072/003
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0656/003
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Portugal
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."